Assessment of the Increased Risk of Infection Following an Ultratrail
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Oct 16, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into whether people who participate in ultramarathon races, like the Grand Raid de la Réunion, are at a higher risk of getting infections after they compete. Researchers believe that after intense and prolonged exercise, the body’s immune system may not work as well, which could make runners more vulnerable to illnesses, especially common infections like colds, throat infections, and urinary tract infections.
To take part in the study, you need to be over 18 years old and sign up for one of the specific races mentioned. You also need to live with someone who can help by answering questions about your health before and after the race. If you don’t speak French or are under legal protection, you won’t be eligible to join. Participants will be asked to share information about their health and any infections they experience during the study period. This trial aims to better understand how endurance running affects the immune system and could help improve safety for future participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \> 18 years
- • Participating in a Grand Raid de la Réunion 2023 race (Mascareignes, Trail de Bourbon, Diagonale des Fous)
- • Have a companion living under the same roof during the week preceding the race and the 21 days following the race and who agrees to answer the questionnaires
- • Do not object to the research
- Exclusion Criteria:
- • Do not understand French
- • A protected adult (guardianship or curatorship) or under court protection
About Centre Hospitalier Universitaire De La Réunion
The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Denis, , Réunion
Patients applied
Trial Officials
Nicolas BOUSCAREN, MD
Principal Investigator
CHU de la Réunion
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported